choline has been researched along with Hypertrophy, Left Ventricular in 1 studies
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Choline treatment may represent a new therapeutic strategy for optimizing myocardial metabolism in the context of hypertrophy and heart failure." | 1.51 | Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway. ( Cui, YL; Lu, Y; Wu, Q; Xu, M; Xue, RQ; Yong, SY; Yu, XJ; Zang, WJ; Zhao, M; Zuo, XT, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, M | 1 |
| Xue, RQ | 1 |
| Lu, Y | 1 |
| Yong, SY | 1 |
| Wu, Q | 1 |
| Cui, YL | 1 |
| Zuo, XT | 1 |
| Yu, XJ | 1 |
| Zhao, M | 1 |
| Zang, WJ | 1 |
1 other study available for choline and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Choline; Disease Models, Animal; Energy Met | 2019 |